Clinical Edge Journal Scan

Textured breast implants may raise risk of cancer relapse


 

Key clinical point : The use of textured implants in reconstructive surgery after breast cancer mastectomy was significantly associated with lower rates of disease-free survival compared to smooth implants, but no difference was noted in local and regional recurrence-free survival based on implant texture.

Major finding: Rates of disease-free survival were significantly lower among breast cancer patients who received textured breast implants compared to those who received smooth implants (hazard ratio 3.054); the association was even stronger among patients with stage II or III tumors (HR 8.874).

Study details : The data come from a cohort study of 650 women representing 687 cases of breast cancer who were treated at a single center in South Korea between January 1, 2011, and December 31, 2016.

Disclosures: The study received no outside funding. The researchers had no financial conflicts to disclose.

Citation: Lee K-T et al. JAMA Surg. 2020 Oct 7. doi: 10.1001/jamasurg.2020.4124.

Recommended Reading

One-month delay in cancer treatment linked to increase in mortality
MDedge Hematology and Oncology
Study supports genetic testing in older women with breast cancer
MDedge Hematology and Oncology
New cancer drugs may have saved more than 1.2 million Americans
MDedge Hematology and Oncology
‘Test all patients with cancer’: One in eight have inherited mutations
MDedge Hematology and Oncology
Pembrolizumab approved for triple-negative breast cancer
MDedge Hematology and Oncology
Using telehealth to deliver palliative care to cancer patients
MDedge Hematology and Oncology
Pregnancy outcomes ‘favorable’ after BRCA breast cancer treatment
MDedge Hematology and Oncology
Black women show higher rates of three breast cancer subtypes
MDedge Hematology and Oncology
Immediate breast reconstruction after chemotherapy doesn’t hurt survival
MDedge Hematology and Oncology
Vacuum-assisted biopsy predicts post-treatment residual disease in breast cancer
MDedge Hematology and Oncology